Force Energy Corp. (OTC.BB:FORC) maintains a 50% working interest in County Line Energy Corp. interest in the Hayter Well (10D Hayter 10-8-40-1 W4M) located in Alberta, Canada. The well was spudded in January 2007 and drilled to a total depth. The well logs revealed a gas zone of 4 to 5 meters of thickness in a shallow zone and a heavy oil pay zone of 2 meters of thickness in the target Dina Sand zone. Although the results in the Dina sand were lower than expected and a decision was made to case the well in 2007, should prices rise in the future, the Hayter could produce an economic well.
County Line Energy completed a $650,000 3D seismic program covering nine sections of land in pursuit of a potential multi well heavy oil drilling opportunity. The geological model was based on interpretation from a previous well, which produced 16,000 barrels of heavy oil. The seismic program was designed to determine whether the structure found in this well existed to a larger extent on the subject property. The 3D seismic revealed an extremely large anomaly with similar characteristics. The nature of this large anomaly suggested that a multi well drilling opportunity might exist. Although this well will likely be completed as a producing well the results of the drilling have negated the ultimate potential of the Hayter property.
The current oil price spike started back in February when the rebellion in Libya’s oil fields put a stop to the country’s daily exports of 1.5 million barrels of crude. That has caused oil speculators to push up the price.
The U.S. economy added hundreds of thousands of jobs this year. That means gasoline demand could increase this year as more workers join the daily commute.
The devastating earthquake and tsunami in Japan put further pressure on oil prices. Japan is expected to boost oil and natural gas imports while some of its nuclear power plants are offline.
Oil surged above $113 per barrel on weekend following a drop in the dollar and continued jitters about shipments from the world’s major oil suppliers.
Oil stocks are on fire right now. The search for oil is on! The value of oil companies not only increases when they discover the black gold, but also when the price of oil goes up.
More about FORC at: www.forceenergycorp.com
DARA BioSciences Reports That SurgiVision Has Completed a Commercial Alliance With Brainlab AG!
DARA Presently Owns Over 500,000 Shares and Warrants of SurgiVision, Inc.
DARA BioSciences, Inc. (Nasdaq:DARA), reported today that SurgiVision, Inc., a privately held company, and Brainlab AG, announced on April 11 a collaboration aimed at integrating SurgiVision’s ClearPoint(R) product line with Brainlab’s iMRI product line, with particular focus on local delivery of drugs and other therapeutic agents to precision targets in the brain under magnetic resonance imaging (MRI) guidance. DARA presently owns over 500,000 shares and warrants of SurgiVision.
Last June, SurgiVision received 510(k) clearance from the Food and Drug Administration (FDA) to market their ClearPoint system in the United States for general neurological interventional procedures.
Brainlab and SurgiVision stated that they believe the integration of their technologies will allow patient-specific treatment planning, simplified clinical workflows and optimal delivery of drugs to the brain. Under the terms of the agreement, Brainlab received the right to sell SurgiVision’s ClearPoint product line, including the right to exclusively sell ClearPoint products in the neurological drug delivery field, and Brainlab made an investment in SurgiVision. SurgiVision will continue to sell its ClearPoint product line directly for all applications outside the neurological drug delivery field.
Also, DARA’s two leading drug candidates have been successfully studied in clinical trials, and DARA is preparing for additional clinical studies during the first half 2011. Selected 2010 highlights include:
* Announcement of a Clinical Trial Collaboration Agreement with the Symptom Management & Drug Development, Community Oncology & Prevention Trials Group, Division of Cancer Prevention; National Cancer Institute (NCI) to advance the clinical study of KRN5500;
* Completion of a successful Phase 1a clinical study for DB959 program;
* Enhancement of patent portfolio to 88 granted patents and 60 pending applications (US and foreign);
* Receipt of equity investments in excess of $7.9 million, with CEO Richard A Franco Sr. personally investing approximately $350,000; and,
* Receipt of approximately $500,000 in grant awards.
About DARA BioSciences, Inc.
DARA BioSciences, Inc. is a clinical biopharmaceutical development company that acquires promising therapeutic candidates and develops them through proof of concept (pre-phase III) in humans for subsequent sale or out-licensing to larger pharmaceutical companies. Presently DARA has two drug candidates with cleared IND (Investigational New Drug) Applications from the United States FDA advancing through clinical development:
1. KRN5500 for the treatment of neuropathic pain;
2. DB959 for the treatment of type 2 diabetes.
DARA has a pipeline of diverse drug candidates at various stages of development, with 88 US and foreign granted patents and 60 pending applications.
More about DARA at: www.darabiosciences.com
Motorola Solutions, Inc. (NYSE:MSI) reported the addition of Service from the Start with Device Management to its services portfolio tailored for enterprise customers.
Taking a completely new approach to mobile device management, the new service integrates break/fix repair and support with device management in a single program from a trusted vendor. Combining best-of-breed depot facilities with tight process integration from problem detection to resolution, the service simplifies the process of enabling device management as part of the support program.
This helps IT departments gain better visibility into the devices in the operational environment, lower the total cost of ownership for their mobility investments, and leverage a single platform for strategic business improvement.
Vishay Intertechnology, Inc. (NYSE:VSH), will release results for the first quarter ending April 2, 2011 before the NYSE opens on May 3, 2011.
The Dow Chemical Company (NYSE:DOW) and OPX Biotechnologies, Inc. (OPXBIO) reported that the two companies are collaborating to develop an industrial scale process for the production of bio-based acrylic acid from renewable feedstocks.
Sign Up For Free Stock Alerts At http://crwewallstreet.com/signup
************************************************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEWallStreet publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEWallStreet.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.(Read more at http://crwewallstreet.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received seven thousand five hundred ($7,500) dollars in cash for one week of advertising services from a third party (FullCorp Trading Ltd.) for Force Energy Corporation (FORC.OB).
